Nasdaq-listed Enlivex to buy an additional $21M in RAIN

Nasdaq-listed biopharmaceutical company Enlivex has secured $21 million to purchase additional RAIN, the native token of Rain Protocol, Cointelegraph reported. The company also announced it has approved a $20 million share buyback plan. Rain is a prediction market protocol based on Arbitrum (ARB).